Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00856986 · ClinicalTrials.gov registry record · Phase 3
The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes
A Phase 3 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 3
- Development phase
- 987
- Enrollment target
NCT00856986 is a Phase 3 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 987 participants.
The verdict
NCT00856986, a Phase 3 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 987 participants
- Enrollment target
Study Summary
This trial is conducted in Europe and North America. The aim of this clinical trial is to assess and compare the effect of insulin detemir in combination with liraglutide and metformin versus liraglutide and metformin in subjects with type 2 diabetes. Subjects will continue their own pre-trial metformin treatment during the trial.
Interventions
- DRUG metformin
- DRUG liraglutide
- DRUG insulin detemir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 987 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00856986
The ClinicalTrials.gov registry entry for NCT00856986 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 987 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which metformin is the first listed.
NCT00856986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00856986 about?
NCT00856986 is a clinical study titled "The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes". This trial is conducted in Europe and North America. The aim of this clinical trial is to assess and compare the effect of insulin detemir in combination with liraglutide and metformin versus liraglutide and metformin in subjects with type 2 diabetes. Subjects will continue their own pre-trial metfo...
What is the current status of trial NCT00856986?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 987 participants. The study started on 2009-03. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00856986?
The interventions under investigation include: metformin (DRUG), liraglutide (DRUG), insulin detemir (DRUG).
Who is sponsoring clinical trial NCT00856986?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.